Abbott Laboratories (SWX:ABT)

Abbott Laboratories Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 27, 2024	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	172,473	177,778	160,908	177,007	220,030	165,979
Market Cap Growth	15.86%	10.48%	-9.10%	-19.55%	32.56%	11.57%
Enterprise Value	177,810	184,566	168,372	183,370	228,163	178,402
Last Close Price	106.00	92.12	89.75	95.58	109.83	94.33
PE Ratio	15.57	14.69	33.52	27.72	34.28	41.94
PS Ratio	5.03	4.68	4.76	4.39	5.60	5.42
PB Ratio	4.42	4.10	4.92	5.19	6.70	5.68
P/TBV Ratio	11.30	10.96	31.28	55.76	-	-
P/FCF Ratio	-	30.89	37.77	24.53	27.91	32.77
P/OCF Ratio	-	22.92	26.32	19.98	22.92	23.74
EV/Sales Ratio	5.18	4.86	4.99	4.54	5.81	5.83
EV/EBITDA Ratio	19.13	19.01	19.11	16.02	19.64	22.94
EV/EBIT Ratio	27.29	27.17	27.69	21.76	27.19	36.92
EV/FCF Ratio	-	32.07	39.52	25.41	28.94	35.23
Debt / Equity Ratio	0.27	0.32	0.41	0.49	0.53	0.60
Debt / EBITDA Ratio	1.14	1.38	1.47	1.41	1.47	2.18
Debt / FCF Ratio	-	2.40	3.14	2.30	2.23	3.48
Asset Turnover	-	0.54	0.54	0.58	0.58	0.49
Inventory Turnover	-	2.92	2.81	3.37	3.56	3.22
Quick Ratio	-	1.05	1.00	1.06	1.28	1.14
Current Ratio	-	1.67	1.64	1.63	1.85	1.72
Return on Equity (ROE)	-	30.91%	15.11%	19.01%	20.49%	13.91%
Return on Assets (ROA)	-	6.06%	6.11%	7.61%	7.79%	4.86%
Return on Capital (ROIC)	8.76%	7.95%	8.24%	10.34%	10.64%	6.61%
Return on Capital Employed (ROCE)	-	11.10%	12.20%	15.50%	14.80%	9.00%
Earnings Yield	6.42%	6.83%	3.00%	3.62%	2.93%	2.40%
FCF Yield	-	3.24%	2.65%	4.08%	3.58%	3.05%
Dividend Yield	2.10%	2.20%	1.95%	1.86%	1.51%	1.44%
Payout Ratio	-	28.62%	62.13%	47.73%	45.28%	56.95%
Buyback Yield / Dilution	0.07%	0.06%	0.85%	1.40%	-0.17%	-0.28%
Total Shareholder Return	2.17%	2.26%	2.80%	3.26%	1.34%	1.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.